{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:18:59Z","timestamp":1783189139311,"version":"3.54.6"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T00:00:00Z","timestamp":1777766400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["2023Y9038"],"award-info":[{"award-number":["2023Y9038"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2023J01600"],"award-info":[{"award-number":["2023J01600"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014125","name":"Fujian Provincial Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017686","name":"Fujian Provincial Health Technology Project","doi-asserted-by":"publisher","award":["2023CXA017"],"award-info":[{"award-number":["2023CXA017"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejps.2026.107545","type":"journal-article","created":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T22:17:32Z","timestamp":1777846652000},"page":"107545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Physiologically-based pharmacokinetic modeling of belimumab for systemic lupus erythematosus patients to predict the withdrawal time in pregnancy and vaccine time in infants"],"prefix":"10.1016","volume":"222","author":[{"given":"Peilin","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenming","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongfang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuihong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107545_bib0001","unstructured":"CellCept, 2017. Mycophenolate Mofetil: full prescribing information (Label). U.S. Food Drug Admin."},{"key":"10.1016\/j.ejps.2026.107545_bib0003","unstructured":"GlaxoSmithKline, 2017. Benlysta (Belimumab) Review Report. Ministry of Health, Labour and Welfare, Tokyo, Japan."},{"key":"10.1016\/j.ejps.2026.107545_bib0004","unstructured":"GlaxoSmithKline, 2025. BENLYSTA (belimumab) Prescribing Information. U.S. Food and Drug Administration, Silver Spring, MD, USA."},{"key":"10.1016\/j.ejps.2026.107545_bib0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-0897.1994.tb00866.x","article-title":"A follow-up study of immunoglobulin levels and autoantibodies in an unselected pregnant population","volume":"31","author":"Ailus","year":"1994","journal-title":"Am. J. Reprod. Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/bfm.2021.0110","article-title":"Monoclonal antibodies during breastfeeding","volume":"16","author":"Anderson","year":"2021","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.ejps.2026.107545_bib0007","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/annrheumdis-2016-209770","article-title":"EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and\/or antiphospholipid syndrome","volume":"76","author":"Andreoli","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2026.107545_bib0008","article-title":"Biologics during pregnancy and breastfeeding among women with rheumatic diseases: safety clinical evidence on the road","volume":"12-2021","author":"Beltagy","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107545_bib0009","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard-2022-223684","article-title":"Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero","volume":"82","author":"Bitter","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2026.107545_bib0010","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001167","article-title":"P137 Concentrations of subcutaneously administered belimumab in human breast milk in a woman with systemic lupus erythematosus: a case report","volume":"11","author":"Blomjous","year":"2024","journal-title":"Lupus. Sci. Med."},{"key":"10.1016\/j.ejps.2026.107545_bib0011","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/ckj\/sfab049","article-title":"Maternal, foetal and child consequences of immunosuppressive drugs during pregnancy in women with organ transplant: a review","volume":"14","author":"Boulay","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.ejps.2026.107545_bib0012","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2020-217101","article-title":"Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial","volume":"79","author":"Brunner","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2026.107545_bib0013","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/s41591-019-0568-2","article-title":"A single T cell epitope drives the neutralizing anti-drug antibody response to natalizumab in multiple sclerosis patients","volume":"25","author":"Cassotta","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejps.2026.107545_bib0014","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2010-07-295444","article-title":"Pregnancy outcomes after maternal exposure to rituximab","volume":"117","author":"Chakravarty","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2026.107545_bib0015","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/0961203317703495","article-title":"A randomized, open-label study to investigate the effect of belimumab on pneumococcal vaccination in patients with active, autoantibody-positive systemic lupus erythematosus","volume":"26","author":"Chatham","year":"2017","journal-title":"Lupus."},{"key":"10.1016\/j.ejps.2026.107545_bib0016","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.3899\/jrheum.111587","article-title":"Effect of belimumab on vaccine antigen antibodies to influenza, pneumococcal, and tetanus vaccines in patients with systemic lupus erythematosus in the BLISS-76 trial","volume":"39","author":"Chatham","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejps.2026.107545_bib0017","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/cpt.3031","article-title":"Physiologically-based pharmacokinetic modeling of anti-tumor necrosis factor agents for inflammatory bowel disease patients to predict the withdrawal time in pregnancy and vaccine time in infants","volume":"114","author":"Chen","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107545_bib0018","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1097\/MPH.0000000000001871","article-title":"Dysfunctional immune system reconstitution after Rituximab exposure In Utero","volume":"43","author":"Clark","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejps.2026.107545_bib0019","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.3389\/fimmu.2020.01920","article-title":"Update on transplacental transfer of IgG subclasses: impact of maternal and fetal factors","volume":"11","author":"Clements","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0020","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s40262-017-0538-0","article-title":"Physiologically based pharmacokinetic modeling of renally cleared drugs in pregnant women","volume":"56","author":"Dallmann","year":"2017","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107545_bib0021","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10928-023-09849-9","article-title":"Mechanistic incorporation of FcRn binding in plasma and endosomes in a whole body PBPK model for large molecules","volume":"50","author":"de Witte","year":"2023","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"Suppl 1","key":"10.1016\/j.ejps.2026.107545_bib0022","first-page":"S34","article-title":"Physiologic changes during pregnancy and impact on small-molecule drugs, biologic (Monoclonal Antibody) disposition, and response","volume":"63","author":"Eke","year":"2023","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107545_bib0023","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2026.107545_bib0024","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/ar2966","article-title":"The role of dendritic cells in the pathogenesis of systemic lupus erythematosus","volume":"12","author":"Fransen","year":"2010","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.ejps.2026.107545_bib0025","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/rheumatology\/keaf128","article-title":"Belimumab concentrations and immunogenicity in relation to drug effectiveness and safety in SLE within a Swedish real-world setting","volume":"64","author":"Gomez","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejps.2026.107545_bib0026","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/keab247.197","article-title":"P202\u2003Administering live vaccines to infants exposed to biologic and targeted synthetic DMARDs in-utero for maternal treatment of rheumatic disease: a systematic review of the literature","volume":"60","author":"Goulden","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejps.2026.107545_bib0027","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/cpt.2815","article-title":"Physiologically-based pharmacokinetic modeling of Omalizumab to predict the pharmacokinetics and pharmacodynamics in pediatric patients","volume":"113","author":"Guo","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2026.107545_bib0028","article-title":"Pregnancy planning in lupus and APS patients","volume":"2-2024","author":"Haase","year":"2024","journal-title":"Front. Lupus"},{"key":"10.1016\/j.ejps.2026.107545_bib0029","doi-asserted-by":"crossref","unstructured":"Han, L., Hou, Z., Li, J., Wang, Y., Li, H., 2025. Biologic therapy for immune-mediated inflammatory diseases during pregnancy and lactation: efficacy, safety, and challenges. Precis. Medic. 2, 100029. https:\/\/doi.org\/10.1016\/j.prmedi.2025.100029.","DOI":"10.1016\/j.prmedi.2025.100029"},{"key":"10.1016\/j.ejps.2026.107545_bib0030","article-title":"Placental and breast milk transfer of belimumab in three patients with systemic lupus erythematosus treated throughout pregnancy","volume":"9","author":"Higuchi","year":"2025","journal-title":"Mod. Rheumatol. Case Rep."},{"key":"10.1016\/j.ejps.2026.107545_bib0031","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/ajmg.a.35223","article-title":"Teratogenicity of mycophenolate confirmed in a prospective study of the European Network of Teratology Information Services","volume":"158A","author":"Hoeltzenbein","year":"2012","journal-title":"Am. J. Med. Genet. a"},{"key":"10.1016\/j.ejps.2026.107545_bib0032","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12016-021-08917-7","article-title":"A contemporary update on the diagnosis of systemic lupus erythematosus","volume":"63","author":"Huang","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0033","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/bdr2.2091","article-title":"Belimumab use during pregnancy: interim results of the belimumab pregnancy registry","volume":"115","author":"Juliao","year":"2023","journal-title":"Birth Defects Res."},{"key":"10.1016\/j.ejps.2026.107545_bib0034","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/ajg.2008.71","article-title":"Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy","volume":"104","author":"Kane","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejps.2026.107545_bib0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13036-025-00506-y","article-title":"Engineering FcRn binding kinetics dramatically extends antibody serum half-life and enhances therapeutic potential","volume":"19","author":"Ko","year":"2025","journal-title":"J. Biol. Eng."},{"key":"10.1016\/j.ejps.2026.107545_bib0036","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s40262-020-00977-w","article-title":"Physiologically based pharmacokinetic modeling framework to predict neonatal pharmacokinetics of transplacentally acquired emtricitabine, Dolutegravir, and Raltegravir","volume":"60","author":"Liu","year":"2021","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107545_bib0037","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1186\/s12884-024-06701-x","article-title":"Pregnancy outcomes and risk factors analysis in patients with systemic lupus erythematous","volume":"24","author":"Lu","year":"2024","journal-title":"BMC Pregn. ChildBirth"},{"key":"10.1016\/j.ejps.2026.107545_bib0038","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1080\/19420862.2018.1506648","article-title":"A minimal physiologically based pharmacokinetic model to investigate FcRn-mediated monoclonal antibody salvage: effects of K(on), K(off), endosome trafficking, and animal species","volume":"10","author":"Maas","year":"2018","journal-title":"MAbs."},{"key":"10.1016\/j.ejps.2026.107545_bib0039","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/jcph.1540","article-title":"Integration of ontogeny into a physiologically based pharmacokinetic model for monoclonal antibodies in premature infants","volume":"60","author":"Malik","year":"2020","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107545_bib0040","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-073980","article-title":"Advances in the management of systemic lupus erythematosus","volume":"383","author":"Morand","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ejps.2026.107545_bib0041","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10928-017-9559-4","article-title":"A generic whole body physiologically based pharmacokinetic model for therapeutic proteins in PK-Sim","volume":"45","author":"Niederalt","year":"2018","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2026.107545_bib0042","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0043","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41372-022-01528-w","article-title":"Immunoglobulin G and subclasses placental transfer in fetuses and preterm newborns: a systematic review","volume":"43","author":"Pereira","year":"2023","journal-title":"J. Perinatol."},{"key":"10.1016\/j.ejps.2026.107545_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.02.025","article-title":"Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed In utero","volume":"23","author":"Prentice","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejps.2026.107545_bib0045","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/psp4.12927","article-title":"The quest for balance between capturing data and model complexity: a quantitative clinical pharmacology approach applied to monoclonal antibodies","volume":"12","author":"Pressly","year":"2023","journal-title":"CPT. Pharmacometrics. Syst. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107545_bib0046","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nri2155","article-title":"FcRn: the neonatal fc receptor comes of age","volume":"7","author":"Roopenian","year":"2007","journal-title":"Nature Rev. Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0047","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2026.107545_bib0048","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ard.2025.02.023","article-title":"EULAR recommendations for use of antirheumatic drugs in reproduction, pregnancy, and lactation: 2024 update","volume":"84","author":"R\u00fcegg","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejps.2026.107545_bib0049","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1093\/rheumatology\/keac551","article-title":"British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.ejps.2026.107545_bib0050","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/rheumatology\/keac558","article-title":"Executive Summary: british Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids","volume":"62","author":"Russell","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.ejps.2026.107545_bib0051","doi-asserted-by":"crossref","unstructured":"Russell, M.D., Dey, M., Flint, J., Davie, P., Allen, A., Crossley, A., Frishman, M., Gayed, M., Hodson, K., Khamashta, M., Moore, L., Panchal, S., Piper, M., Reid, C., Saxby, K., Schreiber, K., Senvar, N., Tosounidou, S., van de Venne, M., Warburton, L., Williams, D., Yee, C.-S., Gordon, C., Giles, I., BSR Standards, A., Group, G.W., 2022. British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids. Rheumatology. 62, e48\u2013e88. https:\/\/doi.org\/10.1093\/rheumatology\/keac551.","DOI":"10.1093\/rheumatology\/keac551"},{"key":"10.1016\/j.ejps.2026.107545_bib0052","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/bfm.2020.0068","article-title":"Belimumab concentrations in maternal serum and breast milk during breastfeeding and the safety assessment of the infant: a case study","volume":"15","author":"Saito","year":"2020","journal-title":"Breastfeed. Med."},{"key":"10.1016\/j.ejps.2026.107545_bib0053","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/acr.24130","article-title":"2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.ejps.2026.107545_bib0054","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/art.41191","article-title":"2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases","volume":"72","author":"Sammaritano","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.ejps.2026.107545_bib0055","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41467-018-03620-2","article-title":"BAFF-neutralizing interaction of belimumab related to its therapeutic efficacy for treating systemic lupus erythematosus","volume":"9","author":"Shin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2026.107545_bib0056","doi-asserted-by":"crossref","first-page":"B41","DOI":"10.1016\/j.ajog.2022.09.001","article-title":"Society for maternal-fetal medicine consult series #64: systemic lupus erythematosus in pregnancy","volume":"228","author":"Silver","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ejps.2026.107545_bib0057","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10928-024-09907-w","article-title":"Longitudinal modeling of efficacy response in patients with lupus nephritis receiving belimumab","volume":"51","author":"Simeoni","year":"2024","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejps.2026.107545_bib0058","article-title":"Delayed B-cell maturation and attenuated vaccine responses in infants exposed to B-cell depleting therapies <em>in utero<\/em>","volume":"12","author":"Soomann","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0059","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.repbre.2023.10.003","article-title":"A regression approach for assessing large molecular drug concentration in breast milk","volume":"3","author":"Stratigakis","year":"2023","journal-title":"Reprod. Breed."},{"key":"10.1016\/j.ejps.2026.107545_bib0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jcph.104","article-title":"Population pharmacokinetics of belimumab following intravenous administration in patients with systemic lupus erythematosus","volume":"53","author":"Struemper","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107545_bib0061","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s40262-017-0586-5","article-title":"Population pharmacokinetic and pharmacodynamic analysis of Belimumab administered subcutaneously in healthy volunteers and patients with systemic lupus erythematosus","volume":"57","author":"Struemper","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107545_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106838","article-title":"Application of physiologically based pharmacokinetic modeling of novel drugs approved by the US food and drug administration","volume":"200","author":"Sun","year":"2024","journal-title":"Eur. J. Pharmaceutical Sci."},{"key":"10.1016\/j.ejps.2026.107545_bib0063","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40262-023-01238-2","article-title":"Clinical pharmacokinetics, pharmacodynamics, and immunogenicity of Anifrolumab","volume":"62","author":"Tang","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107545_bib0064","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.pedneo.2025.06.003","article-title":"Placental transfer of rituximab in extremely low birth weight infants: KREC as a tool for neonatal immune assessment","volume":"66","author":"Terukina","year":"2025","journal-title":"Pediatrics Neonatol."},{"key":"10.1016\/j.ejps.2026.107545_bib0065","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"2020","key":"10.1016\/j.ejps.2026.107545_bib0066","article-title":"New mechanisms and therapeutic targets in systemic Lupus Erythematosus","volume":"6","author":"Tian","year":"2025","journal-title":"MedComm. (2020)"},{"key":"10.1016\/j.ejps.2026.107545_bib77","series-title":"Chapter 11: The UK immunisation schedule","author":"UK Health Security Agency","year":"2025"},{"key":"10.1016\/j.ejps.2026.107545_bib0067","article-title":"The molecular mechanisms that underlie the immune biology of anti-drug antibody formation following treatment with monoclonal antibodies","volume":"11-2020","author":"Vaisman-Mentesh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0068","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40262-024-01370-7","article-title":"Pharmacokinetics of monoclonal antibodies throughout pregnancy: a systematic literature review","volume":"63","author":"van Gendt","year":"2024","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2026.107545_bib0069","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1177\/09612033241245549","article-title":"Considering belimumab during pregnancy: a more viable option over time","volume":"33","author":"Vela-Casasempere","year":"2024","journal-title":"Lupus."},{"key":"10.1016\/j.ejps.2026.107545_bib0070","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/ecco-jcc\/jjad172","article-title":"Validation of the pharmacokinetic model for anti-tnf\u03b1 clearance in infants exposed to anti-tnf\u03b1 during pregnancy","volume":"18","author":"Wieringa","year":"2024","journal-title":"J. Crohns. Colitis."},{"key":"10.1016\/j.ejps.2026.107545_bib0071","article-title":"Factors affecting the FcRn-mediated transplacental transfer of antibodies and implications for vaccination in pregnancy","volume":"8-2017","author":"Wilcox","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejps.2026.107545_bib0072","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/bcp.16263","article-title":"Inter-regional pharmacokinetics and exposure-response analyses of belimumab in patients with system lupus erythematosus","volume":"91","author":"Wu","year":"2025","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107545_bib0073","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1177\/0961203316642309","article-title":"Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program","volume":"25","author":"Yapa","year":"2016","journal-title":"Lupus."},{"key":"10.1016\/j.ejps.2026.107545_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2025.107301","article-title":"Physiologically-based pharmacokinetic modeling of natalizumab for multiple sclerosis patients to predict the withdrawal time in pregnancy and vaccine time in infants","volume":"215","author":"Zhou","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107545_bib0075","doi-asserted-by":"crossref","first-page":"891","DOI":"10.2147\/IJWH.S461640","article-title":"Systemic Lupus Erythematosus and pregnancy complications and outcomes: a mendelian randomization study and retrospective validation","volume":"16","author":"Zhu","year":"2024","journal-title":"Int. J. Womens Health"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T17:54:27Z","timestamp":1783187667000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":75,"alternative-id":["S0928098726001193"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107545","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physiologically-based pharmacokinetic modeling of belimumab for systemic lupus erythematosus patients to predict the withdrawal time in pregnancy and vaccine time in infants","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107545","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107545"}}